Browsing: Poolbeg

Poolbeg Pharma (LSE:POLB) has raised £3.5 million through a placing of 58.3 million new ordinary shares at 6 pence each, representing a 16% discount to the previous closing price. Executive Chair Cathal Friel participated in the fundraising with a £250,000 investment